Market Research Logo

Vascular Grafts - Medical Devices Pipeline Assessment, 2018

Vascular Grafts - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Vascular Grafts - Medical Devices Pipeline Assessment, 2018 provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Vascular Grafts Overview
3 Products under Development
3.1 Vascular Grafts - Pipeline Products by Stage of Development
3.2 Vascular Grafts - Pipeline Products by Segment
3.3 Vascular Grafts - Pipeline Products by Territory
3.4 Vascular Grafts - Pipeline Products by Regulatory Path
3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date
3.6 Vascular Grafts - Ongoing Clinical Trials
4 Vascular Grafts - Pipeline Products under Development by Companies
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development
4.2 Vascular Grafts - Pipeline Products by Stage of Development
5 Vascular Grafts Companies and Product Overview
5.1 Ariste Medical LLC Company Overview
5.1.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 BioSurfaces, Inc. Company Overview
5.2.1 BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cardiojustable LLC (Inactive) Company Overview
5.3.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardiovate Company Overview
5.4.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview
5.5 Colorado Therapeutics, LLC Company Overview
5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 CryoLife Inc Company Overview
5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.8 DSM Biomedical BV Company Overview
5.8.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
5.9 Eqalix Inc Company Overview
5.9.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 FIT Biotech Oy Company Overview
5.10.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview
5.11 Gel-Del Technologies, Inc. Company Overview
5.11.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Humacyte Inc Company Overview
5.12.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Innovia LLC Company Overview
5.13.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.14 LeMaitre Vascular Inc Company Overview
5.14.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Merit Medical Systems Inc Company Overview
5.15.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Northwestern University Company Overview
5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.17 Peca Labs, Inc. Company Overview
5.17.1 Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 PetVivo Holdings Inc Company Overview
5.18.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 RegenaGraft Company Overview
5.19.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
5.20 Secant Group LLC Company Overview
5.20.1 Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview
5.21 Terumo Aortic Company Overview
5.21.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
5.22 TTK Healthcare Ltd Company Overview
5.22.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.23 Universidad de Los Andes Company Overview
5.23.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview
5.24 University of Louisville Company Overview
5.24.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
5.25 University of Pittsburgh Company Overview
5.25.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.26 VA Boston Healthcare System Company Overview
5.26.1 VA Boston Healthcare System Pipeline Products & Ongoing Clinical Trials Overview
5.27 VesselTek BioMedical LLC Company Overview
5.27.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.28 VESSL Therapeutics Ltd Company Overview
5.28.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 W. L. Gore & Associates Inc Company Overview
5.29.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Xeltis AG Company Overview
5.30.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
6 Vascular Grafts- Recent Developments
6.1 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
6.2 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results
6.3 Apr 27, 2018: Fit Biotech: Appointment of Tommi Holopainen as CFO and as a Member of the Management Team
6.4 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.5 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
6.6 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
6.7 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
6.8 Mar 15, 2018: FIT Biotech's Review of Operations and Financial Statement 2017 published
6.9 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results
6.10 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017
6.11 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.12 Jan 23, 2018: Jonathan Vande Geest, University Of Pittsburg Has Received A NIH Grant To Construct A Biomeimetic, Small Diameter Vascular Graft
6.13 Jan 18, 2018: FIT Biotech’s CEO to change - Erkki Pekkarinen appointed as a new CEO
6.14 Jan 18, 2018: FIT Biotech Oy Announces Senior Management Changes
6.15 Jan 16, 2018: Secant Group Develops the First Synthetic Regenerative Cardiovascular Graft
6.16 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.17 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results
6.18 Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)
6.19 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.20 Oct 25, 2017: Bard Announces Third Quarter Results
6.21 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.22 Oct 02, 2017: Humacyte Awarded $3.4 Million Contract Award from the U.S. Department of Defense
6.23 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors
6.24 Sep 26, 2017: ETR featured in peer-reviewed journal EuroIntervention
6.25 Sep 22, 2017: Xeltis CTO on the future of heart valve therapy at PCR London Valves
6.26 Sep 15, 2017: Fit Biotech Half-yearly Financial Report January 1 - June 30, 2017
6.27 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY
6.28 Aug 23, 2017: FIT Biotech Oy: FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board
6.29 Aug 14, 2017: Governor McAuliffe Announces LifeNet Health to Invest $12.25 million, Create 321 New Jobs in City of Virginia Beach
6.30 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%
6.31 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
6.32 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.33 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017
6.34 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
6.35 Jul 20, 2017: Positive progression of ETR clinical trials at WCPCCS
6.36 Jul 07, 2017: MPSC New COO Glendy Wang on Board
6.37 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Vascular Grafts - Pipeline Products by Stage of Development
Table 2: Vascular Grafts - Pipeline Products by Segment
Table 3: Vascular Grafts - Pipeline Products by Territory
Table 4: Vascular Grafts - Pipeline Products by Regulatory Path
Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date
Table 6: Vascular Grafts - Ongoing Clinical Trials
Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development
Table 8: Vascular Grafts - Pipeline Products by Stage of Development
Table 9: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Drug Eluting Vascular Graft - Product Status
Table 11: Drug Eluting Vascular Graft - Product Description
Table 12: BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: BioFunc - APC Vascular Graft - Product Status
Table 14: BioFunc - APC Vascular Graft - Product Description
Table 15: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Adjustable SPA Shunt - Product Status
Table 17: Adjustable SPA Shunt - Product Description
Table 18: Cardiovate Pipeline Products & Ongoing Clinical Trials Overview
Table 19: NeoVessel Vascular Graft - Product Status
Table 20: NeoVessel Vascular Graft - Product Description
Table 21: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Xenograft Implant - Peripheral Vascular Disease - Product Status
Table 23: Xenograft Implant - Peripheral Vascular Disease - Product Description
Table 24: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Synergraft Xenograft Vascular Graft - Product Status
Table 26: Synergraft Xenograft Vascular Graft - Product Description
Table 27: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Lifeline TEBV - Lower Limb - Product Status
Table 29: Lifeline TEBV - Lower Limb - Product Description
Table 30: LifeLine TEBV - Pediatric - Product Status
Table 31: LifeLine TEBV - Pediatric - Product Description
Table 32: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Small Diameter Vascular Graft - Product Status
Table 34: Small Diameter Vascular Graft - Product Description
Table 35: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: CardioVessel - Product Status
Table 37: CardioVessel - Product Description
Table 38: LCL Graft - Product Status
Table 39: LCL Graft - Product Description
Table 40: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview
Table 41: GTU X-Graft - Product Status
Table 42: GTU X-Graft - Product Description
Table 43: GTU X2-Graft - Product Status
Table 44: GTU X2-Graft - Product Description
Table 45: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 46: VasoGraft - Product Status
Table 47: VasoGraft - Product Description
Table 48: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: HUMACYL - Peripheral Artery Disease - Product Status
Table 50: HUMACYL - Peripheral Artery Disease - Product Description
Table 51: HUMACYL Graft - Vascular Trauma - Product Status
Table 52: HUMACYL Graft - Vascular Trauma - Product Description
Table 53: Humacyte Inc - Ongoing Clinical Trials Overview
Table 54: HUMACYL - Peripheral Artery Disease - A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Use as a Vascular Bypass or Interposition Vessel in Patients with Limb-threatening Peripheral Arterial Trauma
Table 55: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 56: 4mm Vascular Graft - Product Status
Table 57: 4mm Vascular Graft - Product Description
Table 58: LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: LifeSpan ePTFE Vascular Graft - Product Status
Table 60: LifeSpan ePTFE Vascular Graft - Product Description
Table 61: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Self-expanding Covered Stent Graft - Product Status
Table 63: Self-expanding Covered Stent Graft - Product Description
Table 64: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table 65: ePTFE Graft - Peripheral Arterial Disease - Product Status
Table 66: ePTFE Graft - Peripheral Arterial Disease - Product Description
Table 67: Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 68: exGraft - Product Status
Table 69: exGraft - Product Description
Table 70: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Peripheral Vascular Graft - Product Status
Table 72: Peripheral Vascular Graft - Product Description
Table 73: RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
Table 74: RegenaVasc - Product Status
Table 75: RegenaVasc - Product Description
Table 76: Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Regenerative Cardiovascular Graft - Product Status
Table 78: Regenerative Cardiovascular Graft - Product Description
Table 79: Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Triplex Advanced Vascular Graft - Product Status
Table 81: Triplex Advanced Vascular Graft - Product Description
Table 82: TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Chitra Vascular Graft - Product Status
Table 84: Chitra Vascular Graft - Product Description
Table 85: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview
Table 86: SiSgraft - Product Status
Table 87: SiSgraft - Product Description
Table 88: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Vascular Graft System - Product Status
Table 90: Vascular Graft System - Product Description
Table 91: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Biomimetic Vascular Graft - Product Status
Table 93: Biomimetic Vascular Graft - Product Description
Table 94: VA Boston Healthcare System Pipeline Products & Ongoing Clinical Trials Overview
Table 95: SelfWrap - Product Status
Table 96: SelfWrap - Product Description
Table 97: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 98: VTek Graft - Product Status
Table 99: VTek Graft - Product Description
Table 100: VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 101: MultiGeneGraft - Product Status
Table 102: MultiGeneGraft - Product Description
Table 103: W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 104: GORE VIABAHN Endoprosthesis - Product Status
Table 105: GORE VIABAHN Endoprosthesis - Product Description
Table 106: W. L. Gore & Associates Inc - Ongoing Clinical Trials Overview
Table 107: GORE VIABAHN Endoprosthesis - Post-approval Study of the Gore Viabahn Endoprosthesis for the Treatment of In-stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Table 108: GORE VIABAHN Endoprosthesis - Post-market Study: Evaluation of the GORE VIABAHN Endoprosthesis for the Treatment of Popliteal Artery Aneurysm
Table 109: GORE VIABAHN Endoprosthesis - The Utility of GP1101 Relative to Surgical Bypass in the Treatment of Femoral / Popliteal Arterial Symptomatic Peripheral Arterial Disease
Table 110: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 111: Endogenous Tissue Restoration (ETR) Cardiovascular Graft - Product Status
Table 112: Endogenous Tissue Restoration (ETR) Cardiovascular Graft - Product Description
Table 113: Glossary
1.2 List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development
Figure 2: Vascular Grafts - Pipeline Products by Segment
Figure 3: Vascular Grafts - Pipeline Products by Territory
Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path
Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date
Figure 6: Vascular Grafts - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report